Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
Undemocratic WTO Processes Produce Shameful Result on Intellectual Property and Covid at 12th WTO Ministerial